HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,000 | -6.7% | 125 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | +36.4% | 125 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $11,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | -8.3% | 125 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $12,000 | -14.3% | 125 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | -12.5% | 125 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | +6.7% | 125 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $15,000 | +36.4% | 125 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $11,000 | -15.4% | 125 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $13,000 | -7.1% | 125 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | +27.3% | 125 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | +22.2% | 125 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $9,000 | -10.0% | 125 | -26.5% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | +25.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | +14.3% | 170 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | 0.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |